CORONA Remedies Secures ANVISA Brazil GMP Certification for Ahmedabad Facilities
Corona Remedies Ltd 路 Others (Uncategorized) 路 22 Oct 2026, 4:33 pm
CORONA Remedies Secures ANVISA Brazil GMP Certification for Ahmedabad Facilities CORONA Remedies has received Good Manufacturing Practice (GMP) Compliance Certification from Brazil鈥檚 health regulatory agency, ANVISA, on 22nd Oct'26. The approval covers both its Oral Solid Dosage (OSD) manufacturing facility and its Hormone manufacturing facility located at Bhayla, Ahmedabad. This key regulatory clearance validates international quality compliance and enhances the company's export potential into Latin American pharmaceutical markets.
Original exchange filing (PDF)
More announcements from Corona Remedies Ltd
- Intimation of Participation in Analyst / Investor Conference 路 16 Nov 2026
- Intimation of Participation in Analyst / Investor Conference 路 07 Nov 2026
- Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the second quarter and half year ended September 30, 2026 路 05 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- Audio Recording of Q2H1FY27 Earnings Conference Call with Analysts / Investors 路 02 Nov 2026
- Intimation for Analyst / Investor Meet 路 31 Oct 2026
- Analyst / Investor Presentation 路 31 Oct 2026
- Press Release on Financial Results for second quarter and half year ended on September 30, 2026 路 31 Oct 2026
